Home > Balance Sheet > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Capital Work in Progress

    Back to Balance Sheet
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹542 Cr₹419 Cr₹1,066 Cr₹921 Cr₹1,218 Cr

What is the latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS ?

The latest Capital Work in Progress ratio of GLENMARK PHARMACEUTICALS is ₹542 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹542 Cr
Mar2024₹419 Cr
Mar2023₹1,066 Cr
Mar2022₹921 Cr
Mar2021₹1,218 Cr

How is Capital Work in Progress of GLENMARK PHARMACEUTICALS Trending?

Years Capital Work in Progress % Change
Mar2025 ₹542 Cr
29.25
Mar2024 ₹419 Cr
-60.66
Mar2023 ₹1,066 Cr
15.71
Mar2022 ₹921 Cr
-24.36
Mar2021 ₹1,218 Cr -

Compare Capital Work in Progress of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹57,670.4 Cr 0.6% 2.4% 52.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

0.6%

2.4%

52.9%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses